Brochure: Cell Therapy Development
From expanding rare, antigen-specific T cells to fully characterizing them, learn how our capabilities are making cell therapy development more efficient.
Poster: Rapid Generation of Production Cell Lines with Superior Titers and >99% Monoclonality for Complex Antibody Molecules
See how the Opto CLD 2.0 Workflow enables rapid generation of cell lines secreting antibodies for both traditional and non-traditional antibodies while acquiring a superior data package.
Poster: Linking Phenotypic Data to Gene Expression Using the OptoSeq™ Single Cell 3′ mRNA Library Kit
Find out how the OptoSeq™ Single Cell 3′ mRNA Library Kit workflow enables automated, on-chip, bead-based capture of mRNA for reverse transcription, bar-coding, export and direct preparation for NGS.
Application Note: Profile and Recover Polyfunctional T Cells Using Multiplexed Cytokine Secretion Assays
Learn how you can easily profile multiple secreted cytokines from live T cells and multiplex with other functional assays.
Webinar: Antibody Discovery – Select Better Lead Candidates in Under 1 Week
Learn how we enable lead candidate down-selection in 1 day by performing functional characterization during primary screening. Case studies highlight how our customers are dramatically accelerating development of next-generation antibody therapeutics.
Datasheet: Opto™ CLD 2.0 Workflow
Overview of the Opto CLD 2.0 workflow and representative results.
Datasheet: OptoSeq™ Single Cell 3′ mRNA Library Kit
Overview of the OptoSeq kit and workflow.
Datasheet: Cytotoxicity Assay
Learn how to track the kinetics of T cell-tumor cell killing behavior in real time.
Datasheet: Single Cell Cytokine Assays
Review assay overview and results for measuring the release of up to three cytokines from T cells.
Webinar: Accelerating Antibody Discovery in the Modern Therapeutic Landscape
Learn how antibody discovery is changing in today’s therapeutic space. Case studies presented by Abveris highlight accelerated development of next-generation antibody therapeutics.
Brochure: Beacon System
Discover how the Beacon system shortens timelines, simplifies workflows and reveals detailed data through deep profiling.
Application Note: Rapid Selection of Antibodies Against Membrane Targets using Cell-Binding Assays and the Opto™ Plasma B Discovery
Find out how the Opto Plasma B Discovery workflow simplifies and dramatically reduces the time needed to down-select potential lead candidates, even for difficult membrane proteins.
Application Note: Rapidly Discover and Select Potent Ligand/ Receptor Blocking Antibody Lead Candidates with Opto™ Plasma B Discovery
Discover how you can maximize hit recovery and rapidly down-select blocking antibodies from plasma B cells in a single day.
Application Note: Accessing Greater Antibody Sequence Diversity
See how you can discover >5,000 antigen-specific hits from a single plasma B cell sample and recover >650 unique BCR sequences in under 1 week.
Poster: Rapid Discovery of Therapeutic Antibodies for SARS-CoV-2
Find out how B Cell Antibody Discovery on the Beacon system can be used to rapidly screen human B cell to discover antibodies against difficult targets such as viruses.
Datasheet: TCRseq Well Plate Kit
Review assay overview and results for recovering and amplifying T cell receptor alpha and beta chains.
Datasheet: Culture Station
Learn how you can increase scope, scale, and throughput of workflows run on the Beacon and Lightning platforms.
Application Note: Directly Link T Cell Phenotype and Function to Genotype with the Opto Cell Therapy Development 1.0 Workflow
Review use cases for CAR-T cell screening and TCR discovery.